Clinical rationale for the use of various teraflex formulations in osteoarthrosis
The paper provides a rationale for using Teraflex with a manifest symptom-modifying effect in patients with osteoarthritis (OA). It is noted that the use of agents that are potentially able to modify cartilage metabolic processes attracts attention above all due to the possibility of achieving a per...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
IMA-PRESS LLC
2010-12-01
|
| Rangatū: | Современная ревматология |
| Ngā marau: | |
| Urunga tuihono: | https://mrj.ima-press.net/mrj/article/view/324 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|